• twitter
Marine Drugs

Marine Drugs

Implantable Bioresorbable Scaffold with FCS: The Future of Hematopoietic Therapy
October 31, 2025
Implantable Bioresorbable Scaffold with FCS: The Future of Hematopoietic Therapy

On August 28, 2025, Anisimova et al. published an article in Marine Drugs, titled "Implantable Bioresorbable Scaffold with Fucosylated Chondroitin Sulfate as a Promising Device for Delayed Stimulation of Hematopoiesis". The research validates a novel method for sustained hematopoietic support. The central innovation involves incorporating Fucosylated Chondroitin Sulfate (FCS), a potent glycosaminoglycan derived from marine […]

Read More >
Marine-derived Chitosan-based Matrix Nanoparticles with pH-Responsive PSS Loading
October 15, 2025
Marine-derived Chitosan-based Matrix Nanoparticles with pH-Responsive PSS Loading

On September 19, 2025, Xu et al. from the Key Laboratory of Marine Drugs of the Ministry of Education, and related institutions published an article in the journal Marine Drugs titled "Novel pH-Responsive PSS-Loaded Chitosan Matrix Nanoparticles Ameliorate Pressure Overload-Induced Cardiac Hypertrophy." This study focuses on addressing the therapeutic challenge of pressure overload-induced cardiac hypertrophy. […]

Read More >
Categories
Recent Posts
Novel Sulfated Oligosaccharide DP9: A Potent Galectin-3 Inhibitor for Pancreatic Cancer TherapyNovel Sulfated Oligosaccharide DP9: A Potent Galectin-3 Inhibitor for Pancreatic Cancer Therapy
Effects on Ulcerative Colitis of Fucoidan and Its Derivative from <em>Saccharina japonica</em>Effects on Ulcerative Colitis of Fucoidan and Its Derivative from Saccharina japonica
Vaterite/Fucoidan Hybrid MicroparticlesVaterite/Fucoidan Hybrid Microparticles
Chitosan-Mediated Expression of <em>Caenorhabditis elegans fat-1</em> and <em>fat-2</em> in <em>Sparus aurata</em>Chitosan-Mediated Expression of Caenorhabditis elegans fat-1 and fat-2 in Sparus aurata
  • twitter
Quick Links
Contact Us
Copyright © CD BioGlyco. All Rights Reserved.
  • twitter
Top